Physician Photo

Elizabeth M. Vancott, MD

Associate Pathologist, Massachusetts General Hospital

Medical Director, Coagulation Service

Associate Professor of Pathology, Harvard Medical School

Dr. Van Cott is an invited expert participant at the College of American Pathologists consensus conferences in coagulation. She is a strong advocate of coagulation laboratory guidelines and standards.

Departments
Department of Pathology

Specialties

  • MassGeneral Hospital for Children
  • Stroke Services
  • Hemophilia and Thrombosis
Clinical Interests
Coagulation
Hemoglobin Electrophoresis
Locations
Boston: Massachusetts General Hospital
Medical Education
MD, Harvard Medical School
Residency, Massachusetts General Hospital
Board Certifications
Clinical Pathology, American Board of Pathology
Gender
Female
Patient Age Group
Adult and pediatric
Accepting New Patients
Accepting New Patients

Biography

Elizabeth Van Cott, MD is Director of the Coagulation Laboratory and Medical Director of the Core Laboratory at Massachusetts General Hospital and Associate Professor of Pathology at Harvard Medical School. She is President of the North American Specialized Coagulation Laboratory Association (NASCOLA). She is an advisor for the Area Committee on Hematology for the Clinical and Laboratory Standards Institute (CLSI), and is actively involved in writing coagulation laboratory guidelines for CLSI. She is an inaugural member of the new Standards Committee of the College of American Pathologists (CAP), and she recently completed a six-year term on the CAP Coagulation Resource Committee. She has over 100 publications in the field of coagulation.  She is associate editor, section editor, or editorial board member for multiple journals.  She serves on the steering committee for the inaugural THSNA (Thrombosis and Hemostasis Societies of North America) summits in 2012 and 2014, and serves on the inaugural THSNA Board of Directors. She was an invited expert participant at the two most recent CAP consensus conferences in coagulation which generated consensus guidelines on Laboratory Monitoring of Anticoagulant Therapy as well as Thrombophilia.

Research

Research interests include:

  • Clinically-oriented studies in thrombosis and hemostasis

  • Research is focused on coagulation, in particular, diagnostic coagulation testing and heparin-induced thrombocytopenia (HIT), including new anticoagulants for the treatment of HIT

Publications

View my most recent publications at PubMed

  1. The effects of dabigatran on lupus anticoagulant, diluted plasma thrombin time, and other specialized coagulation assays. Kim YA, Gosselin R, Van Cott EM. Int J Lab Hematol. 2014 Dec 17. doi: 10.1111/ijlh.12319. [Epub ahead of print] No abstract available.
  2. Activated protein C resistance testing for factor V Leiden. Kadauke S, Khor B, Van Cott EM.Am J Hematol. 2014 Dec;89(12):1147-50.
  3. Increased transfusion-free survival following auxiliary pig liver xenotransplantation. Yeh H, Machaidze Z, Wamala I, Fraser JW, Navarro-Alvarez N, Kim K, Schuetz C, Shi S, Zhu A, Hertl M, Elias N, Farkash EA, Vagefi PA, Varma M, Smith RN, Robson SC, Van Cott EM, Sachs DH, Markmann JF. Xenotransplantation. 2014 Sep-Oct;21(5):454-64. doi: 10.1111/xen.12111. Epub 2014 Aug 1.

Massachusetts General Hospital
55 Fruit Street
Boston, MA 02114-2696

Phone: 617-726-9468
Fax: 617-726-3256